|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/24 | |||
| A61K 31/573 |
| (11) | Patento numeris | 2838559 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13718822.3 |
| Europos patento paraiškos padavimo data | 2013-04-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-02-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/057892 |
| Data | 2013-04-16 |
| (87) | Numeris | WO 2013/156472 |
| Data | 2013-10-24 |
| (30) | Numeris | Data | Šalis |
| 201261624988 P | 2012-04-16 | US | |
| 201261668864 P | 2012-07-06 | US | |
| 201361785626 P | 2013-03-14 | US |
| (72) |
KERSCHBAUMER, Randolf, AT
VOELKEL, Dirk, AT
SCHEIFLINGER, Friedrich, AT
EHRLICH, Hartmut, FR
|
| (73) |
Baxalta Incorporated,
1200 Lakeside Drive, Bannockburn, IL 60015,
US
Baxalta GmbH, Zählerweg 4, 6300 Zug, CH |
| (54) | COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND GLUCOCORTICOIDS |
| COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND GLUCOCORTICOIDS |